uce
ProgressImage ProgressImage
Gennex Laboratories Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code 531739 border-img ISIN Demat INE509C01026 border-img Book Value 7.62 border-img NSE Symbol N.A border-img Div & Yield % 0 border-img Market Cap ( Cr.) 298.41 border-img P/E 18.22 border-img EPS 0.72 border-img Face Value 1
Quarters
ParticularsDec 2024
()
Sep 2024
()
Jun 2024
()
Gross Sales25.2824.6921.33
Other Operating Income2.071.820.00
Other Income 0.000.002.46
Total Income27.3526.5123.79
Total Expenditure 21.7820.9818.41
PBIDT5.565.535.38
Interest 0.410.470.29
PBDT5.165.065.09
Depreciation0.200.050.17
Tax0.750.850.75
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax4.214.164.17
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item4.214.164.17
    
EPS (Unit Curr.)0.190.180.18
EPS (Adj) (Unit Curr.)0.190.180.18
Calculated EPS (Unit Curr.)0.190.180.18
Calculated EPS (Adj) (Unit Curr.)0.190.180.18
Calculated EPS (Ann.) (Unit Curr.)0.740.730.73
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.740.730.73
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity22.7422.7422.74
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)21.9922.4025.22
PBDTM(%)20.4120.4923.86
PATM(%)16.6516.8519.55
x
x
×
Let's Chat
close
refresh